• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthBrainstorm Health

Brainstorm Health: Apple Health Records, Safe Injection Sites, Novartis Earnings

By
Sy Mukherjee
Sy Mukherjee
Down Arrow Button Icon
By
Sy Mukherjee
Sy Mukherjee
Down Arrow Button Icon
January 24, 2018, 2:32 PM ET

Hello, readers! This is Sy.

America’s opioid epidemic is so brutal and pervasive that it’s literally contributing to lower life expectancy across the nation and hitting the U.S. workforce participation rate. Prescription painkiller and opioid overdoses are now killing more than 30,000 Americans per year. The federal government has begun taking some steps to stem the tide, including by making it easier for non-doctors to prescribe opioid addiction treatment. But the city of Philadelphia is taking things a step further, with officials across the local government announcing Tuesday that they would whole-heartedly endorse a program of “safe injection sites”—i.e., locations where drug users can use their product of choice while in the company of medical professionals who could save them from an overdose.

This is, undoubtedly, a controversial proposition. These safe injection sites wouldn’t be run by the city, but rather outsourced to private organizations who step up. Critics say it would amount to a sanctioning of illegal drug use; some public health advocates reply that, in a time of medical crisis, it’s better to prioritize people’s health and safety, even if it means (in some ways) giving dangerous and illegal drug use a pass.

While officials like Pennsylvania’s new state attorney general have said they wouldn’t target individuals who use or operate such sites (if they’re eventually set up), there would be significant tensions between the city, state, and federal government on the program—especially given Attorney General Jeff Sessions’ hardline position on recreational drug use. One DEA spokesperson has already said that the “proposed government-sanctioned sites would encourage and normalize heroin use, thereby increasing demand for opiates.”

The injection sites would by no means be the only avenue for fighting opioid addiction, Philadelphia officials say. A comprehensive strategy encouraging non-opioid treatments and medication-assisted addiction therapy must also be part of the strategy. But the heart wrenching question for the city is: Is it better to keep going with a zero-tolerance policy, or to make sure that those who are addicted to opioids stay alive long enough to recover?

Read on for the day’s news.

Sy Mukherjee
@the_sy_guy
sayak.mukherjee@fortune.com

DIGITAL HEALTH

Apple wants to put your medical records into its Health app. Apple is making yet another big move into the health care space—and this time, it involves electronic medical records, those essential bits of health data which (for some reason) still require many Americans to use a fax machine to ascertain. (I speak from personal experience.) And Apple's line up an impressive roster of major medical facilities for the upcoming feature. "The updated Health Records section within the Health app brings together hospitals, clinics and the existing Health app to make it easy for consumers to see their available medical data from multiple providers whenever they choose," wrote the company in a press release. "Johns Hopkins Medicine, Cedars-Sinai, Penn Medicine and other participating hospitals and clinics are among the first to make this beta feature available to their patients." More on this later.(Apple)

INDICATIONS

Novartis reports stronger than expected turnaround under new incoming CEO. Swiss pharma giant Novartis' incoming CEO, Vas Narasimhan, outlined an ambitious and rosy-eyed prospect for the company in the coming years during an earnings calls Wednesday. Narasimhan predicted 12 "major" product launches in the next two years while reporting a better-than-expected $12.9 billion in net revenues in the fourth quarter of 2017. Two treatments Novartis expects to grow dramatically? Entresto, a heart failure drug, and Cosentyx, used to treat psoriasis.(Financial Times)

THE BIG PICTURE

Aetna faces civil fine over HIV status leak. Health insurer Aetna has been fined by New York (a relatively minor $1.15 million civil penalty) over its recent HIV status debacle. Aetna sent out envelopes to some 2,460 HIV-positive New York residents that revealed their HIV statuses through large transparent windows on the front side of the mailers; the company says it will work to revamp its privacy practices in addition to paying the fine.(Reuters)

REQUIRED READING

IBM's Watson Is Going to the Grammys, by Tom Huddleston Jr.

GE's Meltdown May Be the Best Thing to Happen to It, by Geoff Colvin

Why This VC Is Betting on Women, People of Color, and LGBTQ Founders, by Polina Marinova

Google Wanted to Give Away $30 Million for Landing on the Moon. But Nobody Won, by Aric Jenkins

Produced by Sy Mukherjee
@the_sy_guy
sayak.mukherjee@fortune.com

Find past coverage. Sign up for other Fortunenewsletters.
About the Author
By Sy Mukherjee
See full bioRight Arrow Button Icon

Latest in Health

HealthAffordable Care Act (ACA)
A Wisconsin couple was paying $2 a month for an ACA health plan. But as subsidies expire, it’s soaring to $1,600, forcing them to downgrade
By Ali Swenson and The Associated PressDecember 13, 2025
2 hours ago
Julian Braithwaite is the Director General of the International Alliance for Responsible Drinking
CommentaryProductivity
Gen Z is drinking 20% less than Millennials. Productivity is rising. Coincidence? Not quite
By Julian BraithwaiteDecember 13, 2025
3 hours ago
Nicholas Thompson
C-SuiteBook Excerpt
I took over one of the most prestigious media firms while training for an ultramarathon. Here’s what I learned becoming CEO of The Atlantic
By Nicholas ThompsonDecember 13, 2025
5 hours ago
Healthmeal delivery
Factor Meals Review 2025: Tester Approved
By Christina SnyderDecember 12, 2025
20 hours ago
Donald Trump
HealthHealth Insurance
‘Tragedy in the making’: Top healthcare exec on why insurance will spike to subsidize a tax cut to millionaires and billionaires
By Nick LichtenbergDecember 12, 2025
21 hours ago
HelloFresh meal delivery service.
Healthmeal delivery
HelloFresh Review : We Tasted Everything so You Don’t Have To
By Christina SnyderDecember 12, 2025
22 hours ago

Most Popular

placeholder alt text
Economy
Tariffs are taxes and they were used to finance the federal government until the 1913 income tax. A top economist breaks it down
By Kent JonesDecember 12, 2025
1 day ago
placeholder alt text
Success
Apple cofounder Ronald Wayne sold his 10% stake for $800 in 1976—today it’d be worth up to $400 billion
By Preston ForeDecember 12, 2025
1 day ago
placeholder alt text
Success
40% of Stanford undergrads receive disability accommodations—but it’s become a college-wide phenomenon as Gen Z try to succeed in the current climate
By Preston ForeDecember 12, 2025
1 day ago
placeholder alt text
Economy
For the first time since Trump’s tariff rollout, import tax revenue has fallen, threatening his lofty plans to slash the $38 trillion national debt
By Sasha RogelbergDecember 12, 2025
22 hours ago
placeholder alt text
Economy
The Fed just ‘Trump-proofed’ itself with a unanimous move to preempt a potential leadership shake-up
By Jason MaDecember 12, 2025
20 hours ago
placeholder alt text
Success
At 18, doctors gave him three hours to live. He played video games from his hospital bed—and now, he’s built a $10 million-a-year video game studio
By Preston ForeDecember 10, 2025
3 days ago
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.